世界の骨移植&代替骨市場2021年-2031年:種類別(同種移植片、代替骨、細胞基質)、用途別(脊椎固定、外傷、関節再建、歯科骨移植、頭蓋顎顔面)、エンドユーザー別(病院、専門医院、その他)

【英語タイトル】Bone Grafts and Substitutes Market By Type (Allografts, Bone grafts substitutes, Cell based matrices), By Application (Spinal fusion, Trauma, Joint reconstruction, Dental bone grafting, Craniomaxillofacial), By End user (Hospitals, Specialty clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが出版した調査資料(ALD23MY011)・商品コード:ALD23MY011
・発行会社(調査会社):Allied Market Research
・発行日:2023年2月
・ページ数:407
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,730 ⇒換算¥848,040見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD9,600 ⇒換算¥1,420,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社は、2021年には2,586.30百万ドルであった世界の骨移植&代替骨市場規模が2031年には4,005.26百万ドルへ上り、予測期間中(2022年~2031年)に年平均4.5%成長すると予測しています。本書では、骨移植&代替骨の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、種類別(同種移植片、代替骨、細胞基質)分析、用途別(脊椎固定、外傷、関節再建、歯科骨移植、頭蓋顎顔面)分析、エンドユーザー別(病院、専門医院、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ)分析、競争状況、企業情報などの項目をまとめました。また、市場調査の対象企業には、Arthrex, Inc.、Johnson & Johnson、Medtronic plc、Stryker Corporation、Baxter International Inc.、Xtant Medical Holdings, Inc.、Integra LifeSciences、NuVasive, Inc.、Zimmer Biomet Holdings, Inc.、Orthofix Holdings, Inc.などが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の骨移植&代替骨市場規模:種類別
- 同種移植片の市場規模
- 代替骨の市場規模
- 細胞基質の市場規模
・世界の骨移植&代替骨市場規模:用途別
- 脊椎固定における市場規模
- 外傷における市場規模
- 関節再建における市場規模
- 歯科骨移植における市場規模
- 頭蓋顎顔面における市場規模
・世界の骨移植&代替骨市場規模:エンドユーザー別
- 病院における市場規模
- 専門医院における市場規模
- その他エンドユーザーにおける市場規模
・世界の骨移植&代替骨市場規模:地域別
- 北米の骨移植&代替骨市場規模
- ヨーロッパの骨移植&代替骨市場規模
- アジア太平洋の骨移植&代替骨市場規模
- 中南米/中東・アフリカの骨移植&代替骨市場規模
・競争状況
・企業情報

骨移植&代替骨の市場規模は、2021年に25億8,630万ドル、2031年には40億5,526万ドルに達すると予測され、2022年から2031年までの年平均成長率は4.5%となる見込みです。
骨移植片と代替物は、欠損または損傷した骨組織を置換または再生するために使用される材料と技術を指します。通常、身体の自然治癒プロセスでは損傷した骨を修復できない場合に使用されます。これらの治療法は、骨折の修復、骨欠損の再建、骨成長の促進を目的とした整形外科手術や歯科手術で一般的に使用されています。
骨移植&代替骨市場の成長を促進する主な要因としては、筋骨格系障害の発生率の増加、高度な骨移植片の開発のための技術進歩、スポーツ傷害の増加などが挙げられます。変形性関節症、骨粗鬆症、その他の骨関連疾患などの筋骨格系疾患の有病率の増加が、骨移植&代替骨の需要を促進しています。骨移植片や代用品は、骨量の回復や治癒促進を目的として使用されることが多く、これらの疾患は骨量減少の原因となるためです。さらに、毎年行われる外科手術の数が増加しており、これらの手術の多くで骨移植片や代用品を使用する必要があります。例えば、骨移植片や代用品を使用することが多い脊椎固定術は、米国で最も急成長している外科手術のひとつです。したがって、こうした手術件数の増加が骨移植片や代用品の需要につながり、市場拡大の原動力にもなっています。
さらに、技術の進歩により、生体適合性が向上し、治癒特性が改善され、感染や拒絶反応のリスクが低減された新しい骨移植片や代用品が開発されています。このような進歩は、より新しく先進的な製品に対する需要を促進しています。さらに、市場の主要企業による新製品発売数の増加が、骨移植&代替骨市場の成長を促進すると予測されています。例えば、2022年2月、Orthofix Medical Inc.は、頸椎および腰椎固定術用の合成生体活性骨移植ソリューションであるOpus BAを発売しました。このように、主要企業による新製品発売の増加は、骨移植&代替骨市場の成長をさらに促進します。
さらに、骨移植&代替骨の需要に対応する市場の主要企業による戦略の採用の増加が、市場の成長を促進する見込みです。例えば、2023年1月、Zimmer Biomet Holdings, Inc.は、軟組織治癒に特化した非上場の医療機器企業であるEmbody, Inc.を買収しました。この買収には、最も困難な整形外科的軟部組織損傷の治癒をサポートするコラーゲンベースのバイオ統合ソリューションのエンボディ社の完全なポートフォリオが含まれます。したがって、このような戦略の採用が増加し、市場の成長を促進すると予想されます。
しかし、認可のための厳しい規制経路が市場の成長を抑制する要因となっています。また、一部の国では有利な償還政策がとられていないことも、市場成長の妨げになると予想されます。さらに、高度な骨移植片に対する需要の増加、利用可能な骨移植&代替骨に関する認知度の向上、整形外科への投資の増加は、骨移植&代替骨市場の主要プレーヤーに有利な機会を提供します。

骨移植&代替骨市場は、種類、用途、エンドユーザーおよび地域に区分されます。
種類別では、同種移植片、代替骨移植片、細胞ベースマトリックスに分類されます。
用途別では、脊椎固定、外傷、頭蓋顎顔面外科、関節再建、歯科骨移植に分類されます。
エンドユーザー別では、市場は病院、専門クリニック、その他に分類されます。
地域別では、北米(米国、カナダ、メキシコ)、欧州(ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域)、アジア太平洋地域(日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋地域)、LAMEA(ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域)に市場を分けて分析しています。

世界の骨移植&代替骨市場で事業を展開する主な主要企業は、Arthrex, Inc.、Johnson & Johnson、Medtronic plc、NuVasive, Inc.、Stryker Corporation、Zimmer Biomet Holdings, Inc.、Baxter International Inc.、Xtant Medical Holdings, Inc.、Integra LifeSciences、Orthofix Holdings, Inc.などです。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの骨移植&代替骨市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、骨移植&代替骨市場の有力な市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・骨移植&代替骨市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・骨移植&代替骨の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
種類別
同種移植片
代用骨移植片
細胞ベースマトリックス

用途別
脊椎固定
外傷
関節再建
歯科用骨移植
頭蓋顎顔面

エンドユーザー別
病院
専門クリニック
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Arthrex, Inc.
Johnson & Johnson
Medtronic plc
Stryker Corporation
Baxter International Inc.
Xtant Medical Holdings, Inc.
Integra LifeSciences
NuVasive, Inc.
Zimmer Biomet Holdings, Inc.
Orthofix Holdings, Inc.

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of orthopedic conditions
3.4.1.2. Increase in demand for dental bone grafts
3.4.1.3. Advancements in bone grafts and substitutes

3.4.2. Restraints
3.4.2.1. High cost of surgeries
3.4.2.2. Ethical & regulatory issues related with bone grafting procedures

3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Allografts
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Allografts Bone Grafts and Substitutes Market by Type
4.3. Bone grafts substitutes
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Bone grafts substitutes Bone Grafts and Substitutes Market by Type
4.4. Cell based matrices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal fusion
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Trauma
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Joint reconstruction
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Dental bone grafting
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Craniomaxillofacial
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Specialty clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End user
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End user
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End user
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End user
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End user
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End user
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End user
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End user
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Arthrex, Inc.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Baxter International Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Johnson & Johnson
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Medtronic plc
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. NuVasive, Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Stryker Corporation
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Zimmer Biomet Holdings, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Orthofix Holdings, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Xtant Medical Holdings, Inc.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Integra LifeSciences
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 02. BONE GRAFTS AND SUBSTITUTES MARKET FOR ALLOGRAFTS, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GLOBAL ALLOGRAFTS BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 04. BONE GRAFTS AND SUBSTITUTES MARKET FOR BONE GRAFTS SUBSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL BONE GRAFTS SUBSTITUTES BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 06. BONE GRAFTS AND SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY REGION, 2021-2031 ($MILLION)
TABLE 07. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 08. BONE GRAFTS AND SUBSTITUTES MARKET FOR SPINAL FUSION, BY REGION, 2021-2031 ($MILLION)
TABLE 09. BONE GRAFTS AND SUBSTITUTES MARKET FOR TRAUMA, BY REGION, 2021-2031 ($MILLION)
TABLE 10. BONE GRAFTS AND SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY REGION, 2021-2031 ($MILLION)
TABLE 11. BONE GRAFTS AND SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY REGION, 2021-2031 ($MILLION)
TABLE 12. BONE GRAFTS AND SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL, BY REGION, 2021-2031 ($MILLION)
TABLE 13. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 14. BONE GRAFTS AND SUBSTITUTES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. BONE GRAFTS AND SUBSTITUTES MARKET FOR SPECIALTY CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. BONE GRAFTS AND SUBSTITUTES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 21. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 23. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 25. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 26. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 27. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 30. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 33. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 34. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 36. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 39. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 42. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 45. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 46. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 55. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 57. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 66. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 71. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 76. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 77. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 78. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 79. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 80. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 81. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 83. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 86. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 87. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 89. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 91. ARTHREX, INC.: KEY EXECUTIVES
TABLE 92. ARTHREX, INC.: COMPANY SNAPSHOT
TABLE 93. ARTHREX, INC.: PRODUCT SEGMENTS
TABLE 94. ARTHREX, INC.: PRODUCT PORTFOLIO
TABLE 95. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 96. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 97. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 98. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 99. BAXTER INTERNATIONAL INC.: KEY STRATERGIES
TABLE 100. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 101. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 102. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 103. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 104. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 105. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 106. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 107. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 108. MEDTRONIC PLC: KEY STRATERGIES
TABLE 109. NUVASIVE, INC.: KEY EXECUTIVES
TABLE 110. NUVASIVE, INC.: COMPANY SNAPSHOT
TABLE 111. NUVASIVE, INC.: PRODUCT SEGMENTS
TABLE 112. NUVASIVE, INC.: PRODUCT PORTFOLIO
TABLE 113. NUVASIVE, INC.: KEY STRATERGIES
TABLE 114. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 115. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 116. STRYKER CORPORATION: PRODUCT SEGMENTS
TABLE 117. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 118. STRYKER CORPORATION: KEY STRATERGIES
TABLE 119. ZIMMER BIOMET HOLDINGS, INC.: KEY EXECUTIVES
TABLE 120. ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 121. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 122. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 123. ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGIES
TABLE 124. ORTHOFIX HOLDINGS, INC.: KEY EXECUTIVES
TABLE 125. ORTHOFIX HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 126. ORTHOFIX HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 127. ORTHOFIX HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 128. ORTHOFIX HOLDINGS, INC.: KEY STRATERGIES
TABLE 129. XTANT MEDICAL HOLDINGS, INC.: KEY EXECUTIVES
TABLE 130. XTANT MEDICAL HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 131. XTANT MEDICAL HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 132. XTANT MEDICAL HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 133. XTANT MEDICAL HOLDINGS, INC.: KEY STRATERGIES
TABLE 134. INTEGRA LIFESCIENCES: KEY EXECUTIVES
TABLE 135. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 136. INTEGRA LIFESCIENCES: PRODUCT SEGMENTS
TABLE 137. INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 138. INTEGRA LIFESCIENCES: KEY STRATERGIES

★調査レポート[世界の骨移植&代替骨市場2021年-2031年:種類別(同種移植片、代替骨、細胞基質)、用途別(脊椎固定、外傷、関節再建、歯科骨移植、頭蓋顎顔面)、エンドユーザー別(病院、専門医院、その他)] (コード:ALD23MY011)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の骨移植&代替骨市場2021年-2031年:種類別(同種移植片、代替骨、細胞基質)、用途別(脊椎固定、外傷、関節再建、歯科骨移植、頭蓋顎顔面)、エンドユーザー別(病院、専門医院、その他)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆